Lemai Keli
Natural health product licensed in Canada
- Other names
- Vasoheme, Vitaheme
- Licence holder
- Sichuan Chuanda West China Pharmaceutical Co., Ltd.
- NPN or DIN-HM
- 80037542
- Status
- Active licence
- Licence date
- 16 November 2012
- Revision date
- 1 May 2018
- Form
- Granules
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Cyperus rotundus L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes et allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Saussurea costus Source : Racine | 0.12475 g | Not calculated |
| Paeonia lactiflora Source : Racine | 0.2495 g | Not calculated |
| Crataegus pinnatifida Source : Fruit | 0.0624 g | Not calculated |
| Cyperus rotundus Source : Rhizome | 0.12475 g | Not calculated |
| Carthamus tinctorius Source : Fleur | 0.2495 g | Not calculated |
| Salvia miltiorrhiza Source : Racine et rhizome | 0.499 g | Not calculated |
Non-medicinal ingredients
Dextrine, Amidon prégélatinisé, Lactose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3 g ; maximum: 6 g | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Traditional Chinese medicine for headache, diziness, chest pain, palpitation due to stagnation of qi and blood.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80037542
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging